

Paul Sax
Dr. Paul Sax is pursuing novel approaches in the field of infectious diseases, with a particular emphasis on HIV. As a Professor of Medicine at Brigham and Women's Hospital, Harvard Medical School, Dr. Sax has dedicated his career to advancing the understanding and treatment of infectious diseases. He serves as the Clinical Director of the Division of Infectious Diseases at Brigham and Women's Hospital, where he oversees clinical operations and contributes to the development of innovative treatment strategies. Holding the prestigious Bruce A. Beal and Robert L. Beal Distinguished Chair in Infectious Diseases, Dr. Sax is recognized for his leadership and expertise in the field. His work is characterized by a commitment to integrating clinical practice with cutting-edge research, ensuring that patients receive the most effective and up-to-date care. Dr. Sax's research interests are centered around clinical trials, infectious diseases, and HIV, where he has made significant contributions to the understanding of disease mechanisms and treatment protocols. In addition to his clinical and research responsibilities, Dr. Sax is deeply involved in medical education. He is known for his engaging teaching style and dedication to mentoring the next generation of healthcare professionals. His role as Editor-in-Chief of Open Forum Infectious Diseases allows him to influence the dissemination of critical research findings and foster dialogue within the medical community. Dr. Sax is also the principal investigator at the BWH AIDS Clinical Trials Unit, where he leads efforts to evaluate new therapies and interventions for HIV. His involvement with the Cost-Effectiveness of Preventing AIDS Complications (CEPAC) Research Group underscores his commitment to improving healthcare delivery and outcomes for individuals living with HIV. Through his extensive work in clinical trials and his contributions to medical literature, Dr. Sax continues to shape the landscape of infectious disease treatment and prevention. His dedication to patient care, research, and education makes him a respected leader in the field, and his efforts are instrumental in advancing the fight against infectious diseases worldwide.
Publications
, xiii-xiv, 2019-09-01
, 1727-1735, 2010-01-01
, 409-416, 2006-09-01
, 1738-1739, 2023-11-09
, 433-455, 2001-06-01
, 620-622, 2010-02-09
, 605-608, 2011-09-15
, 1, 2010-01-01